Internal Medicine, Pulmonary Disease · Lady Lake, FL
NPI
1922067834
Since 2006
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
753 Highway 466
Lady Lake, FL, 32159
Phone (352) 391-5500
Groups this clinician bills Medicare through
Medicare paid, 2024
$306K
3,596 services
Medicare patients, 2024
909
Average age 77
Drug cost, 2024
$664K
1,057 prescriptions
Company payments, 2025
$689
From 12 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Anupama Upadya was code 99214 (office e&m - established), 1,806 times for 830 patients. In total Anupama Upadya billed 3,596 services in 19 codes, and Medicare paid $306K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2009-12-18.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 1,806 | 830 | $98.73 | $178K |
| 94060 Pulmonary Function Testing | Office | 452 | 426 | $29.45 | $13K |
| 94729 Pulmonary Function Testing | Office | 424 | 412 | $43.30 | $18K |
| 94727 Pulmonary Function Testing | Office | 424 | 412 | $34.10 | $14K |
| 99204 Office E&M - New | Office | 185 | 185 | $129.62 | $24K |
| 95800 Sleep Study | Office | 105 | 58 | $102.93 | $11K |
| 99213 Office E&M - Established | Office | 73 | 53 | $69.59 | $5,080 |
| 95810 Sleep Study | Office | 56 | 56 | $481.44 | $27K |
| 95811 Sleep Study | Office | 26 | 25 | $499.58 | $13K |
| 94618 Pulmonary Function Testing | Office | 18 | 18 | $27.09 | $488 |
By year: 2022 $317K for 3,872 services; 2023 $322K for 3,822 services; 2024 $306K for 3,596 services.
Medicare prescription drug claims, 2024
In 2024, the drug Anupama Upadya prescribed most often to Medicare patients was Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter), with 202 prescriptions and refills. In total Anupama Upadya wrote 1,057 Medicare prescriptions that cost $664K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 202 | 477 | 65 | $293K |
| Breo Ellipta Fluticasone/Vilanterol | 112 | 273 | 33 | $103K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 107 | 179 | 56 | $5,854 |
| Prednisone Generic | 74 | 104 | 44 | $248 |
| Montelukast Sodium Generic | 61 | 183 | 21 | $832 |
| Azithromycin Generic | 47 | 57 | 38 | $680 |
| Spiriva Respimat Tiotropium Bromide | 40 | 100 | 15 | $51K |
| Ventolin Hfa Albuterol Sulfate | 29 | 34 | 19 | $2,724 |
| Zolpidem Tartrate Generic | 25 | 73 | Under 11 | $369 |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 23 | 23 | 19 | $201 |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 22 | 41 | Under 11 | $24K |
| Arnuity Ellipta Fluticasone Furoate | 21 | 43 | Under 11 | $8,692 |
| Pramipexole Dihydrochloride Pramipexole Di-Hcl | 18 | 53 | Under 11 | $350 |
| Wixela Inhub Fluticasone Propion/Salmeterol | 15 | 43 | Under 11 | $3,166 |
| Incruse Ellipta Umeclidinium Bromide | 13 | 39 | Under 11 | $14K |
Brand drugs: 658 claims; generic drugs: 399 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Anupama Upadya $689 ($689 in general payments such as food, travel and fees) from 12 companies. The largest payer was Harmony Biosciences LLC with $192.
| Company | Payments | Amount |
|---|---|---|
| Harmony Biosciences LLC HRMY | 4 | $192 |
| Insmed, Inc. INSM | 7 | $129 |
| Grifols USA, LLC | 3 | $90.94 |
| GlaxoSmithKline, LLC. GSK | 4 | $83.08 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 3 | $44.73 |
| Viatris Specialty LLC | 2 | $35.99 |
| Verona Pharma, Inc. VRNA | 2 | $34.2 |
| Lilly USA, LLC LLY | 1 | $18.65 |
| Pulmonx Corporation LUNG | 1 | $17.6 |
| Genzyme Corporation SNY | 1 | $15.36 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.